Clinical trial
Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or…
NCT00352495 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00352495 |
|---|---|
| Title | Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma |
| Official title | A Phase I Study of Vinblastine in Combination With Carboplatin for Children With Newly Diagnosed and Recurrent Low-Grade Gliomas |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Neurofibromatosis Type 1 |
| Intervention type | Drug |
| Interventions | carboplatin, vinblastine sulfate |
| Enrollment | 26 |
| Start date | Jun 1, 2006 |
| Primary completion | Sep 1, 2011 |
| Completion | Mar 1, 2012 |
| First posted | Jul 14, 2006 |
| Last update posted | Feb 13, 2014 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: